Buy stocks
Invest and track all your stocks in one place.
Strides Pharma Science LtdNSE: STAR
NSE: STAR
₹896.80
-1.2
(3 May)
-0.1%
Loading chart
1D
1W
3M
1Y
5Y
Price
₹896.80
Today’s high
₹900.95
Today’s low
₹870.35
52W high
₹911.95
52W low
₹330.35
1Y
167.3%
PE
-53.38
PB
4.01
EPS (TTM)
-22.49
Dividend yield
0.2%
5Y
13.4%
Market cap
₹8,242.5 Cr
Volume
21,465
Average volume
42,621
Insights
STAR has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.
STAR price is above its 200 day moving average
STAR PE is in the low end of its range over the past 2 years
STAR PE is in the lowest 10% across all stocks. The market is valuing it as a value stock on an earnings basis.
STAR has negative earnings and hence the PE is not defined
STAR is in the highest 10% returns in the past year. It is a high momentum stock. High momentum stocks tend to outperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
₹896.80
₹1,663.00
₹1,152.50
₹1,508.40
₹6,332.85
₹3,937.05
1D
-0.1%
+0.9%
-0.1%
-0.7%
+0.7%
-0.7%
1Y
+167.3%
+134.7%
+86.4%
+55.1%
+27.8%
+21.0%
PE
-53.38
42.45
24.40
40.66
20.21
75.55
PB
4.01
5.72
2.40
6.05
3.94
8.24
EPS
-16.80
39.18
47.24
37.10
313.29
52.11
Market cap
Large
Large
Large
Large
Large
Large
Financials
Income statement
Balance sheet
Cash flow
Quarterly
Annual
As of 2022
Revenue
₹3,607.7 Cr
Net income
- ₹202.6 Cr
See stock holdings
Top institutional holders
Quant Money Managers Limited
5.42%
Aditya Birla Sun Life AMC Ltd
5.03%
Capital Research and Management Company
3.32%
Vanguard Group Inc
2.08%
SBI Funds Management Private Limited
1.68%
Top mutual fund holders
American Funds SMALLCAP World Fund
3.32%
Aditya BSL Equity
3.31%
Quant Small Cap Fund
3.09%
Aditya BSL Flexi Cap
2.56%
SBI Magnum Long Term Equity Scheme
2.26%
About Strides Pharma Science
Strides Pharma Science Ltd is a specialty and generic drug manufacturer. The company focuses on developing niche and complex pharmaceutical products across therapeutic segments for regulated and emerging markets. Strides' emerging-market strategy focuses on branded generics for the treatment of chronic therapies. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Company address
Strides House, Bannerghatta Road, Bilekahalli, Bengaluru, KA, 560
Key executives
Name
Title
Age
Dr. Raghunathan Ananthanarayanan
CEO/Director/Managing Director
NA
Mr. Badree Komandur
CFO/Director/Other Corporate Officer
NA
Mr. Arun Kumar
Chairman of the Board/Director/Founder/Managing Director
NA

FAQs

How to Buy Strides Pharma Science Ltd Stock?
What is the Share Price of Strides Pharma Science Ltd?
What is the Market Cap of Strides Pharma Science Ltd?
In which sector / industry does Strides Pharma Science Ltd operate?
What was the revenue of Strides Pharma Science Ltd?
What is the PE ratio of Strides Pharma Science Ltd?
What is the 52 week high price of Strides Pharma Science Ltd?
What is the 52 week low price of Strides Pharma Science Ltd?
Can fractional shares of Strides Pharma Science Ltd be purchased?